Applied Therapeutics, Inc. (APLT): Price and Financial Metrics
GET POWR RATINGS... FREE!
APLT Stock Price Chart Interactive Chart >
APLT Price/Volume Stats
| Current price | $0.84 | 52-week high | $2.73 |
| Prev. close | $0.84 | 52-week low | $0.50 |
| Day low | $0.81 | Volume | 78,900 |
| Day high | $0.88 | Avg. volume | 308,151 |
| 50-day MA | $1.01 | Dividend yield | N/A |
| 200-day MA | $1.00 | Market Cap | 40.37M |
Applied Therapeutics, Inc. (APLT) Company Bio
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY
Latest APLT News From Around the Web
Below are the latest news stories about APPLIED THERAPEUTICS INC that investors may wish to consider to help them evaluate APLT as an investment opportunity.
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial ResultsProgress in Three Phase 3 Trials in Areas of High Unmet Clinical Need, Including Positive Sorbitol Reduction Data from the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency On Track to Report Additional Phase 3 Data Across Multiple Programs in 2023 NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indication |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to start off the trading week with a breakdown of the biggest pre-market stock movers for Monday and what's behind that movement! |
Quite a few insiders invested in Applied Therapeutics, Inc. (NASDAQ:APLT) last year which is positive news for shareholdersWhen a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase... |
Applied Therapeutics to Present at the Cowen 43rd Annual Health Care ConferenceNEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it will participate in a Neuromuscular & Bone Panel at the Cowen 43rd Annual Health Care Conference on Wednesday, March 8, 2023 at 2:10 p.m. ET in Boston. Webcast information for this event will be accessible on the Events |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting off the final trading day of the week with a look at the biggest pre-market stock movers worth watching on Friday! |
APLT Price Returns
| 1-mo | -16.83% |
| 3-mo | N/A |
| 6-mo | -14.11% |
| 1-year | -62.33% |
| 3-year | -97.24% |
| 5-year | N/A |
| YTD | 10.53% |
| 2022 | -91.51% |
| 2021 | -59.34% |
| 2020 | -19.32% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...